ARTICLES BY THIS AUTHOR
- 6/7/2021
FDA accepts Lannett's generic Advair Diskus application
Advair Diskus had a market value of approximately $3 billion for the 12 months ending April 2021, although actual generic market values are expected to be lower. - 6/6/2021
Lupin receives FDA OK for generic Truvada
Emtricitabine and tenofovir disoproxil fumarate tablets had a market value of roughly $2.1 billion. - 6/6/2021
Camber debuts generic Kaletra
Camber's lopinavir and ritonavir tablets are available in 100 mg/25 mg 60-count and 200 mg/50 mg 120-count bottles. - 6/6/2021
SpartanNash, Bonum Health partner on telemedicine services
Telemedicine, powered by Bonum Health, provides SpartanNash shoppers with direct access to board-certified health providers from their smartphones and computers. - 6/6/2021
FDA approves Biogen's Alzheimer's drug Aduhelm
Aduhelm is the first federally approved Alzheimer's treatment in almost two decades. - 6/3/2021
AAM names Black Women’s Health Imperative its 2021 Champion of Access
The annual Champions of Access award acknowledges individuals and organizations that share the Association for Accessible Medicines’ commitment on greater access to affordable medicines. - 6/3/2021
NACDS urges lawmakers to cement pharmacy’s pandemic-era gains
The National Association of Chain Drug Stores emphasized pharmacy’s central position in the nation’s COVID-19 response in urging Congress not to roll back access and its preparedness achieved during the pandemic. - 6/3/2021
FDA approves Scynexis’ Brexafemme
The product — a treatment for vaginal yeast infections — is expected to be launched in the second half of this year. - 6/2/2021
NCPA to CMS: Address 91,500% hike in DIR fees
The typical community pharmacy now pays roughly $81,000 per year in DIR fees, according to research from the National Community Pharmacists Association. - 6/2/2021
Hikma launches estradiol valerate injection
Estradiol valerate injection had a market value of roughly $16 million in the 12 months ending March 2021, according to IQVIA.